CY1110757T1 - Πυραζολο-[1,5-α]πυριμιδινες, διεργασιες, χρησεις και συνθeσεις - Google Patents

Πυραζολο-[1,5-α]πυριμιδινες, διεργασιες, χρησεις και συνθeσεις

Info

Publication number
CY1110757T1
CY1110757T1 CY20101100804T CY101100804T CY1110757T1 CY 1110757 T1 CY1110757 T1 CY 1110757T1 CY 20101100804 T CY20101100804 T CY 20101100804T CY 101100804 T CY101100804 T CY 101100804T CY 1110757 T1 CY1110757 T1 CY 1110757T1
Authority
CY
Cyprus
Prior art keywords
pyrazolo
pyramidines
compositions
processes
hypnosis
Prior art date
Application number
CY20101100804T
Other languages
English (en)
Inventor
Luis Anglada
Albert Palomer
Antonio Guglietta
Original Assignee
Ferrer Internacional, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Internacional, S.A. filed Critical Ferrer Internacional, S.A.
Publication of CY1110757T1 publication Critical patent/CY1110757T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση παρέχει καινοφανείς πυραζολο[1,5-α]πυριμιδίνες, οι οποίες είναι χρήσιμες για την αγωγή ή την πρόληψη του άγχους, της επιληψίας και των διαταραχών ύπνου συμπεριλαμβανομένης της αϋπνίας, και για την επαγωγή καταπράυνσης-ύπνωσης, αναισθησίας, ύπνου και μυοχάλασης.
CY20101100804T 2006-08-04 2010-09-01 Πυραζολο-[1,5-α]πυριμιδινες, διεργασιες, χρησεις και συνθeσεις CY1110757T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83544406P 2006-08-04 2006-08-04
EP06118454A EP1884516A1 (en) 2006-08-04 2006-08-04 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
EP07788165A EP2059521B1 (en) 2006-08-04 2007-08-02 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions

Publications (1)

Publication Number Publication Date
CY1110757T1 true CY1110757T1 (el) 2015-06-10

Family

ID=37864479

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100804T CY1110757T1 (el) 2006-08-04 2010-09-01 Πυραζολο-[1,5-α]πυριμιδινες, διεργασιες, χρησεις και συνθeσεις

Country Status (25)

Country Link
US (1) US8158632B2 (el)
EP (2) EP1884516A1 (el)
JP (1) JP2009545568A (el)
KR (1) KR20090046916A (el)
CN (1) CN101641359A (el)
AR (1) AR062205A1 (el)
AT (1) ATE469906T1 (el)
AU (1) AU2007280412A1 (el)
BR (1) BRPI0715169A2 (el)
CA (1) CA2659969A1 (el)
CL (1) CL2007002262A1 (el)
CY (1) CY1110757T1 (el)
DE (1) DE602007006966D1 (el)
DK (1) DK2059521T3 (el)
ES (1) ES2346810T3 (el)
HK (1) HK1129105A1 (el)
MX (1) MX2009001149A (el)
NO (1) NO20090972L (el)
PL (1) PL2059521T3 (el)
PT (1) PT2059521E (el)
RU (1) RU2458063C2 (el)
SI (1) SI2059521T1 (el)
TW (1) TW200815445A (el)
UY (1) UY30521A1 (el)
WO (1) WO2008015253A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009095742A1 (en) 2008-01-31 2009-08-06 Cellectis New i-crei derived single-chain meganuclease and uses thereof
WO2010053127A1 (ja) * 2008-11-05 2010-05-14 協和発酵キリン株式会社 α1GABAA受容体またはα5GABAA受容体の調整剤
AU2011221075B2 (en) * 2010-02-26 2013-12-19 Mitsubishi Tanabe Pharma Corporation Pyrazolopyrimidine compounds and their use as PDE10 inhibitors
CN102807569B (zh) * 2012-08-21 2015-02-25 四川大学 一种镇静催眠的化合物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US4847256A (en) * 1986-10-16 1989-07-11 American Cyanamid Company 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo(1,5-A)-pyrimidines
EP0521622B1 (en) * 1991-07-03 1997-08-13 PHARMACIA & UPJOHN COMPANY Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
TWI252851B (en) * 2003-07-24 2006-04-11 Ferrer Int 7-substituted 3-nitro-pyrazolo[1,5-a]pyrimidines and compositions and methods related thereto
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
EP1736475A1 (en) * 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates
DE102005028765B4 (de) * 2005-06-22 2016-01-21 Airbus Operations Gmbh Verfahren zur Herstellung eines Verstärkungsprofils
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound

Also Published As

Publication number Publication date
BRPI0715169A2 (pt) 2013-06-11
ATE469906T1 (de) 2010-06-15
MX2009001149A (es) 2009-03-02
TW200815445A (en) 2008-04-01
RU2009107734A (ru) 2010-09-10
CL2007002262A1 (es) 2008-01-18
US8158632B2 (en) 2012-04-17
AU2007280412A1 (en) 2008-02-07
EP2059521B1 (en) 2010-06-02
EP1884516A1 (en) 2008-02-06
KR20090046916A (ko) 2009-05-11
DK2059521T3 (da) 2010-09-27
WO2008015253A1 (en) 2008-02-07
PT2059521E (pt) 2010-08-26
ES2346810T3 (es) 2010-10-20
RU2458063C2 (ru) 2012-08-10
NO20090972L (no) 2009-04-30
CA2659969A1 (en) 2008-02-07
HK1129105A1 (en) 2009-11-20
DE602007006966D1 (de) 2010-07-15
EP2059521A1 (en) 2009-05-20
CN101641359A (zh) 2010-02-03
US20090264448A1 (en) 2009-10-22
AR062205A1 (es) 2008-10-22
PL2059521T3 (pl) 2010-11-30
UY30521A1 (es) 2008-02-29
JP2009545568A (ja) 2009-12-24
SI2059521T1 (sl) 2010-09-30

Similar Documents

Publication Publication Date Title
DK1869049T3 (da) Imidazopyridazinforbindelser
CL2009000405A1 (es) Compuestos derivados de pirrolo [2,3 b] pirazina, inhibidores jak y cyk; y sus usos en el tratamiento de enfermedades inflamatorias, autoinmune y cancer.
ATE316077T1 (de) Pyrimidin-essigsäure derivate geeignet zur behandlung von crth2-bedingten krankheiten
CY1111452T1 (el) Αλογονωμενες πυραζολο [1,5-α]πυριμιδινες, διεργασιες, χρησεις ως προσδεμα υποδοχεα gaba-a, συνθεσεις και ενδιαμεσα
ZA200710379B (en) Pyrrolopyridines useful as inhibitors of protein kinase
UY29796A1 (es) Nuevos compuestos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor
DE502005007427D1 (de) 3-aminoindazole derivate und ihre verwendung zur behandlung sgk-bedingten krankheiten
IL181473A (en) Antibodies @ people @ against @@@ beta @@ preparations that include them and use them
IS7941A (is) Bensasepínafleiður til að meðhöndla taugasjúkdóma
IL178435A0 (en) Beta-carbolines useful for treating inflammatory disease
UA85559C2 (en) Aminobenzophenone compounds
IL185391A0 (en) Quinazolinone t-type calcium channel antagonists
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
EP1814535A4 (en) NITROSED AND NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING EYE DISEASES
TNSN07440A1 (en) Derivatives of pyrido [2,3 -d] pyrimidine, the preparation thereof, and the therapeutic application of the same
CY1110757T1 (el) Πυραζολο-[1,5-α]πυριμιδινες, διεργασιες, χρησεις και συνθeσεις
MY136822A (en) Derivatives of [6, 7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide and their use as inhibitors upon the interaction of cams and leukointegrins
PT1492501E (pt) Métodos de uso de corpos lamelares para propósitos terapêuticos
CY1115760T1 (el) Τικαγρελορη για την θεραπευτικη αγωγη ανευρυσματων κοιλιακης αορτης
UY27955A1 (es) Polimorfo novedoso del n-metil-n-(3-(3-(2- tienilcarbonil) - pirazol- (1,5-o)- pirimidina =7-yl)fenil) acetamida y compuestos y metodos relacionados
CY1115468T1 (el) Ενωσεις υποκατεστημενου ν-(1η-ινδαζολ-4υλ)ιμιδαζο[1,2-α]πυριδινο-3-καρβοηαμιδιου ως αναστολεις cfms